Better Context → Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

astrazeneca cover image
$599
 Posted in: SGLT2i Aug 29 | 2019DAPA-HF @ ESC 2019 on Sunday Sept 1Purchase Blast
astrazeneca cover image
$599
 Posted in: SGLT2i Aug 27 | 2019AZ's Farxiga CKD Development Receives Fast Track DesignationPurchase Blast
$599
 Posted in: SGLT2i Aug 26 | 2019Invokana CREDENCE Filing Accepted by EMA; Dexcom Wins Patent Dispute with AgaMatrixPurchase Blast
adocia and lilly cover image
$599
 Posted in: Basal Insulin, Bolus Insulin Aug 23 | 2019Lilly Wins in Arbitration with AdociaPurchase Blast
astrazeneca cover image
$599
 Posted in: SGLT2i Aug 22 | 2019Thoughts on AZ PRV Purchase and Potential UsesPurchase Blast
$599
 Posted in: Basal Insulin Aug 22 | 2019Biocon’s Glargine Facility Receives EU GMP CertificationPurchase Blast
novo cover image
$599
 Posted in: GLP-1RA Aug 21 | 2019Novo Sues Mylan Over Generic VictozaPurchase Blast
astrazeneca cover image
$599
 Posted in: SGLT2i Aug 20 | 2019Farxiga Positive Topline DAPA-HF ResultsPurchase Blast
medtronic cover image
$599
 Posted in: Glucose Monitoring, Insulin Delivery Aug 20 | 2019Medtronic CY Q2 '19 (FY Q1 '20) Earnings UpdatePurchase Blast
medtronic cover image
$599
 Posted in: Insulin Delivery Aug 16 | 2019Medtronic Extended Wear Infusion SetPurchase Blast
novo cover image
$599
 Posted in: Other Aug 16 | 2019New Novo Nordisk Ph1 Compound With Unknown MOAPurchase Blast
zealand cover image
$599
 Posted in: Dual/triple agonist, Glucagon, Other Aug 15 | 2019Zealand to Launch HypoPal in the US Without a Partner; Zealand Q2 '19 Earnings UpdatePurchase Blast
novo cover image
$599
 Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Other Aug 12 | 2019Novo: Updated FENIX Viewpoint; Novo Q2 '19 London Earnings UpdatePurchase Blast
lilly cover image
$599
 Posted in: Dual/triple agonist Aug 09 | 2019Two New Lilly Ph1 Tirzepatide TrialsPurchase Blast
novo cover image
$599
 Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal Aug 09 | 2019Novo: REDUCE-IT Adcom Readthrough to Oral Sema? MYL Generic Victoza Filed; Q2 '19 Earnings UpdatePurchase Blast
$599
 Posted in: Bolus Insulin, Glucose Monitoring Aug 07 | 2019MannKind and Senseonics Q2 '19 Earnings UpdatesPurchase Blast
xeris cover image
$599
 Posted in: Glucagon Aug 07 | 2019Xeris Q2 ’19 Earnings UpdatePurchase Blast
BD cover image
$599
 Posted in: Insulin Delivery Aug 06 | 2019BD Swatch pump 510(k) withdrawn; BD CY Q2 ’19 (FY Q3 ’19) Earnings UpdatePurchase Blast
insulet cover image
$599
 Posted in: Insulin Delivery Aug 05 | 2019Insulet Q2 '19 Earnings UpdatePurchase Blast
$599
 Posted in: Bolus Insulin, Insulin Delivery, Other, SGLT2i Aug 05 | 2019Forxiga DECLARE EU Approval, BTD For Provention Bio's Teplizumab (PRV-031), And MannKind/One Drop CollaborationPurchase Blast
1 … 68 69 70 71 72 … 95

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.

Contact BradyLog In